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        Introduction 
  The Notch signaling pathway plays a key role at multiple steps 
of morphogenesis during embryonic development as well as in a 
wide variety of processes during adult life. In particular, Notch 
activation appears to fi  nely tune the balance between prolifera-
tion and differentiation of stem and progenitor cells in several 
different settings, including hematopoietic and nervous systems, 
skin, gut, and heart (for reviews see   Bray, 2006  ;   Chiba, 2006  ; 
  Hurlbut et al., 2007  ;   Nemir and Pedrazzini, 2008  ;   Niessen and 
Karsan, 2008  ). Physiological activation of Notch signaling re-
quires cell  –  cell contact and occurs through binding of the Notch 
receptor to one of its ligands (Delta and Jagged in vertebrates 
and Serrate in invertebrates) followed by the proteolytic release 
of the intracellular domain (ICD) of Notch (Notch-ICD) and its 
translocation into the nucleus (  De Strooper et al., 1999  ). Once 
inside the nucleus, Notch-ICD interacts with transcription regula-
tors of the CSL family (CBF1, Su(H), and Lag-1), triggering the 
activation of genes of the hairy and enhancer of split (HES) fam-
ily (  Jarriault et al., 1995  ;   Iso et al., 2003  ). Experimental evidence 
obtained in   Xenopus laevis ,  zebrafi  sh, chicken, and mammals has 
demonstrated that Notch signaling controls mesodermal com-
mitment, including cardiogenic differentiation, during develop-
ment (  Rones et al., 2000  ;   Loomes et al., 2002  ;   Beis et al., 2005  ; 
    Rutenberg et al., 2006  ;   Del Monte et al., 2007  ;   Grego-Bessa 
et al., 2007  ). Of interest, mice lacking the genes encoding either 
Notch receptors or their ligands show early embryonic lethality, 
which is mainly the consequence of cardiovascular abnormalities. 
This observation supports the notion that the Notch pathway essen-
tially participates in the process of cardiac and vascular develop-
ment (  Gridley, 1997  ;   Gridley, 2003  ;   Shawber and Kitajewski, 
2004  ;   Del Monte et al., 2007  ;   Grego-Bessa et al., 2007  ). Sev-
eral other observations also favor this conclusion. In humans, the 
Alagille syndrome, a congenital disorder associated with heart 
abnormalities, has been linked to haploinsuffi  ciency of Jagged1 
(  Li et al., 1997  ;   Oda et al., 1997  ;   McElhinney et al., 2002  ). In mice, 
combined haploinsuffi  ciency of Jagged1 and Notch2 results in 
cardiac defects reminiscent of this syndrome (  McCright et al., 
2002  ). The Notch signaling pathway also appears to be involved 
in cardiac valve development (  Timmerman et al., 2004  ): in hu-
mans, heterozygous mutations disrupt normal development of 
T
he identiﬁ  cation of the molecular mechanisms con-
trolling cardiomyocyte proliferation during the em-
bryonic, fetal, and early neonatal life appears of 
paramount interest in regard to exploiting this information 
to promote cardiac regeneration. Here, we show that 
the proliferative potential of neonatal rat cardiomyocytes 
is powerfully stimulated by the sustained activation of 
the Notch pathway. We found that Notch1 is expressed 
in proliferating ventricular immature cardiac myocytes 
(ICMs) both in vitro and in vivo, and that the number 
of Notch1-positive cells in the heart declines with age. 
Notch1 expression in ICMs paralleled the expression of its 
Jagged1 ligand on non-myocyte supporting cells. The in-
hibition of Notch signaling in ICMs blocked their prolif-
eration and induced apoptosis; in contrast, its activation 
by Jagged1 or by the constitutive expression of its acti-
vated form using an adeno-associated virus markedly 
stimulated proliferative signaling and promoted ICM ex-
pansion. Maintenance or reactivation of Notch signaling 
in cardiac myocytes might represent an interesting target 
for innovative regenerative therapy.
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exciting the possibility that the forced activation of this pathway 
might lead to the expansion of the pool of poorly differentiated, 
committed cardiac cells. 
  Results 
  The number of Notch1-positive, 
BrdU-positive cardiomyocytes 
in vivo declines with age 
  We started by analyzing the number of cycling cells in neonatal 
and adult rat hearts. For this purpose, animals at birth and at 
9 mo of age (adults) were treated with BrdU, and after 1 wk, the 
presence of cells that had incorporated the nucleotide analogue 
was assessed by immunofl  uorescence. In agreement with pub-
lished observations (  Chen et al., 2007  ;   Kang and Koh, 1997  ), 
  >  30% of nuclei of the    -actinin – positive  neonatal  cardiomyo-
cytes scored positive for BrdU incorporation, whereas   <  3% of 
cells had incorporated BrdU in the adult hearts (  Fig. 1, A and B  , 
for representative images at different magnifi  cations; and   Fig. 1 C   
for quantifi  cation). To confi  rm the cardiac lineage specifi  city of 
the proliferating cells, double labeling with the cardiomyocyte-
specifi  c nuclear marker GATA-4 and BrdU was performed on 
heart sections of neonatal rats. In agreement with the    -actinin 
stainings, the nuclei of several proliferating cells scored posi-
tive for both GATA-4 and BrdU (  Fig. 1 D  ). To further confi  rm 
these fi  ndings, heart sections from neonatal and adult animals 
were stained with an antibody against cyclin A, a G1/S marker 
that is only expressed in proliferating cells. A large number 
(    30%) of nuclei in the neonatal hearts scored positive for 
this antibody. In sharp contrast, many fewer cells (  <  3%) were 
the aortic and, occasionally, mitral valves (  Garg et al., 2005  ). 
Although these models demonstrate the importance of Notch 
in heart development, little is known about the cellular and 
molecular mechanisms of Notch function in this district. 
  The emerging concept that the heart is not a postmitotic 
organ but rather a dynamic tissue maintained by a balance be-
tween cell death and cardiomyocyte differentiation from pre-
cursor cells implies the existence of a pool of resident stem cells 
able to trigger heart repair and the maintenance of tissue homeo-
stasis (  Kajstura et al., 2000  ;   Hierlihy et al., 2002  ;   Beltrami et al., 
2003  ;   Oh et al., 2003  ;   Matsuura et al., 2004  ;   Messina et al., 
2004  ;   Laugwitz et al., 2005  ). The understanding of the molec-
ular and cellular mechanisms controlling cardiac precursor cell 
proliferation and differentiation appears of paramount interest 
with regard to exploiting this information to promote cardiac 
regeneration in adults. 
  In this paper, we show that the proliferative potential of im-
mature cardiac myocytes (ICMs) is powerfully stimulated by the 
sustained activation of the Notch pathway. We found that Notch1 
was highly expressed in early neonatal proliferating cardiomyo-
cytes and that its activation protected these cells from apoptosis; 
the ligand Jagged1 was instead mainly detectable in non-myocyte 
cardiac stromal cells. The levels of expression of Notch1 were 
found to decline together with the loss of the cardiomyocyte pro-
liferative potential, both in vitro and in vivo; consistent with this 
observation, the sustained activation of Notch1 determined a re-
markable expansion of cardiac cells in vitro. Similar to the role of 
the Notch pathway in preserving progenitor cells in other tissues, 
these results indicate that immature, still proliferating cardio-
myocytes rely on Notch1 activity for cell renewal, thus raising the 
  Figure 1.       The number of Notch1-positive, BrdU-positive cardio-
myocytes in vivo declines with age.   (A) Low (top)- and high (bottom)-
magniﬁ   cation representative images of heart sections from newborn 
rats, immunostained for BrdU (red) and     -actinin (green). Nuclei were 
marked by DAPI (blue). Arrows indicate proliferating myocardial cells. 
(B) High-magniﬁ  cation representative images of     -actinin  –  positive car-
diac myocytes (green) from newborn rat hearts showing positivity to 
BrdU immunostaining (red). Nuclei were marked by DAPI. (C) Quanti-
ﬁ  cation of BrdU-positive and BrdU/Notch1-double-positive myocardial 
cells in newborn and adult rat hearts. Results indicate mean   ±   SEM, 
  n   = 6. (D) High magniﬁ  cation representative images of heart sections 
from neonatal rats immunostained for GATA-4 (red) and BrdU (green). 
Nuclei were marked by DAPI (blue). Arrows indicate proliferating myo-
cardial cells. (E) Low (top)- and high (bottom)-magniﬁ  cation representa-
tive images of heart sections from newborn rats, immunostained for cyclin 
A (red) and     -actinin (green). Nuclei were stained by DAPI (blue). 
Arrows indicate proliferating myocardial cells. (F) Quantiﬁ  cation of cyclin 
A  –  positive myocardial cells in newborn and adult rats. Results indicate 
mean   ±   SEM,   n   = 6. (G) Low (top)- and high (top)-magniﬁ  cation rep-
resentative images of heart sections from newborn rats showing strong 
immunoreactivity for Notch1 (red) of     -actinin (green)-positive cardio-
myocytes. Arrows indicate Notch1-positive myocardial cells. (H and I) 
High-magniﬁ  cation images of representative cells from a newborn heart 
section showing positivity of BrdU incorporation (green) and expression 
of the Notch1 cell membrane receptor (H) and its activated intracellular 
form (I, red). Nuclei were stained with DAPI. (L) Representative images 
of both newborn (top) and adult (bottom) rat heart sections showing a 
patchy staining for Jagged1 (red) in stromal areas of myocardial tissue, 
the latter positive for     -actinin staining (green). Nuclei were stained 
with DAPI. In A, E, and G  –  L, the largest ﬁ  gure in each panel shows 
ﬂ  uorescence in all three channels; the two smaller panels show the red/
green (top) and red/blue (bottom) channels. Bars: (A, top) 200   μ  m; 
(A, bottom) 10   μ  m; (B and D) 10   μ  m; (E, top) 100   μ  m; (E, bottom) 
10   μ  m; (G, top) 200   μ  m; (G, bottom)   μ  m; (H and I) 10   μ  m. (L) 100   μ  m.     119  NOTCH PATHWAY IN CARDIOMYOCYTES   • Collesi et al. 
  These observations raised the intriguing possibility that 
the Notch1-positive, BrdU-positive cells might represent im-
mature cardiomyocytes that were still in proliferation in the 
neonatal hearts. 
  Notch-1 expression is down-regulated 
during cardiomyocytes differentiation 
  To further investigate the role of Notch in the regulation of car-
diomyocytes proliferation, the expression of the different Notch 
receptors and ligands was analyzed in primary cultures of cells 
extracted from neonatal rat myocardium. To specifi  cally distin-
guish between cardiac myocytes and cardiac stromal cells, we 
obtained cultures highly enriched in    -actinin – positive  cardio-
myocytes by three subsequent sub-plating steps (  >  90% purity; see 
Materials and methods) along with cultures of    -actinin – negative 
detected in adult hearts (  Fig. 1 E   for representative images and 
  Fig. 1 F   for quantifi  cation). Of interest, we noticed that the neo-
natal hearts also contained a large number of    -actinin – positive 
cells that were positive for the expression of the Notch1 recep-
tor (  Fig. 1 G  ). When these neonatal hearts were stained for both 
BrdU incorporation and Notch1 expression, several of the BrdU-
positive cells were found to express Notch1 (  Fig. 1 H  ) and, in 
particular, its activated intracellular form detected by an anti-
body against Val1744 (  Fig. 1 I  ). Upon quantifi  cation,    19%  of 
nuclei in the neonatal hearts were found to be double-positive 
for both BrdU and Notch1 (  Fig. 1 C  ). In both neonatal and adult 
hearts, Jagged1 was not detectable in mature cardiomyo-
cytes, whereas its expression was confi  ned to patchy areas of 
    -actinin  –  negative cells and the endothelial surface lining car-
diac muscle fi  bers (  Fig. 1 L   and not depicted). 
  Figure 2.       Time course of expression of Notch signaling com-
ponents during cardiomyocyte differentiation.   (A) Representative 
images of puriﬁ  ed neonatal cardiomyocytes stained for     -actinin 
(green) at different time points in culture. After 24 h from plating 
(day 1), ICMs are detected as small, round cells expressing poorly 
organized     -actinin; at day 3, they appear larger and show more 
organized sarcomeres; at day 7, they are differentiated, beating 
cells. Nuclei were stained with DAPI. (B) Representative images of 
Nkx2.5-positive cardiomyocytes during their in vitro differentia-
tion. Green,     -actinin; red, Nkx2.5; blue, DNA (DAPI). (C) BrdU 
incorporation along cardiomyocyte differentiation. ICMs (day 1) 
are detected as small, round-shaped, BrdU-positive cells. The 
number of BrdU-positive cardiomyocytes progressively decreases 
along differentiation. Green,     -actinin; red, BrdU; blue, DNA 
(DAPI). The panels show representative images; for quantiﬁ  ca-
tion, see   Fig. 5 C  . (D) Cell cycle distribution of cardiomyocytes 
at different times after plating. (top) Flow cytometry cell cycle 
proﬁ  les after DNA staining using PI and analysis of 10,000 cell 
counts; (bottom) histogram shows cell cycle distribution. Results 
are representative of at least three independent experiments. (E) 
RT-PCR analysis of the expression of individual genes in the Notch 
pathway in puriﬁ  ed cardiomyocytes (CM) and stromal cells (S) 
at the indicated days of culture. RNA from total embryo extracts 
was used as a positive control (+). (F) Western blot analysis of 
Notch1 and Jagged1 proteins in puriﬁ  ed cardiomyocytes (CM) 
and stromal cells (S) at the indicated time points. Notch1 proteins 
were detected in ICMs at day 1 of culture, progressively decreas-
ing along cardiomyocyte differentiation at days 3 and 7. Speciﬁ  c 
signals became apparent in stromal cells only at day 7. Jagged1 
was not detectable in ICMs (day 1), though it progressively 
increased at days 3 and 7. In stromal cells, Jagged1 was ex-
pressed at all time points. (G) Western blot analysis of activated 
Notch1 (p110-ICD) in cardiomyocytes. (H) Cellular localization 
of Notch1 and Jagged1 proteins during cardiomyocyte differ-
entiation. Cardiomyocytes at days 1, 3, and 7 of culture were 
immunostained using antibodies against Notch1, Val1744-ICD, 
Jagged-1 (red), and     -actinin (green); nuclei were marked with 
DAPI (blue). The largest ﬁ  gure in each panel shows ﬂ  uorescence 
in all three channels; the two smaller ﬁ  gures show the blue/green 
(top) and red/blue (bottom) channels. Bars: (A) 50   μ  m; (B, C, 
and H) 10   μ  m.     JCB • VOLUME 183 • NUMBER 1 • 2008  120
time points, these cells expressed high levels of Jagged1, Notch2, 
and its specifi  c downstream effector Hey1 (  Rutenberg et al., 
2006 ).  No  signifi  cant differences in the expression of the puta-
tive target genes of the Notch pathway, such as Hes1-5, Hey1, 
and Hey2, were observed in immature and fully differentiated 
cardiomyocytes, as well as in stromal cells, which indicates that 
regulation of these target genes is also dependent on pathways 
different from Notch (also see the following paragraph). 
  The expression profi  les of the Notch1 and Jagged1 proteins 
in differentiating cardiomyocytes and in the stromal cells were 
further analyzed by Western blotting. A polyclonal antiserum 
directed against the C terminus of Notch1 detected both the 
300-kD, full-length protein and the p120 cleaved transmem-
brane Notch1 subunit in ICMs at day 1 of culture, whereas 
positivity progressively decreased at days 3 and 7 (  Fig. 2 F  ). 
No specifi  c signals were detected in stromal cells at days 1 and 3, 
although these became apparent at day 7. Consistent with the 
RT-PCR fi  ndings, the Jagged1 protein was not expressed in 
ICMs (day 1), though it progressively increased at days 3 and 7. 
In stromal cells, the levels of the protein remained relatively 
high at all time points (  Fig. 2 F  ). Finally, the levels of activated 
Notch1 (ICD) paralleled the expression pattern of the full-length 
protein (  Figs. 2 G   and Fig. S1 A, available at http://www.jcb
.org/cgi/content/full/jcb.200806091/DC1). 
  The cellular localization of Notch1 and Jagged1 proteins 
during cardiomyocytes differentiation was further studied by 
immunofl  uorescence (  Fig. 2 H  ). Staining with an antibody that 
recognizes the C terminus of Notch confi  rmed the expression of 
the protein in ICMs (day 1) and its progressive disappearance 
afterward. Consistent with these fi  ndings, very strong immuno-
reactivity for activated Notch1-ICD (an antibody against Val1744) 
was found in small, round-shaped ICMs at day 1 (  Figs. 2 H   and 
Fig. S1 B), whereas differentiated cardiomyocytes at day 7 were 
almost completely negative. In agreement with the RT-PCR and 
stromal cells (  <  1%     -actinin positivity). Both cultures were 
maintained for 7  –  14 d. In the cardiac myocytes cultures, after 
24 h, cells were small, had a rounded shape, and expressed 
poorly organized     -actinin; we refer to these myocytes as 
ICMs (  Fig. 2 A  , day 1). During the fi  rst week of culture, ICMs 
progressed along their differentiation by increasing in size and 
showed progressively more organized sarcomers; from day 3, 
mature cardiomyocytes started beating. At all time points, in-
cluding day 1, the cells were positive for     -actinin and Nkx2.5 
(  Fig. 2 B  ), which is indicative of their committed cardiomyo-
cyte identity. About 5% of the day-1 immature ICMs scored 
positive for BrdU incorporation; this percentage decreased to 
    2% and     1.4% at days 3 and 7 after plating (see   Fig. 2 C   for 
representative images and   Fig. 5 C   for quantifi  cation). Consis-
tent with the BrdU incorporation results, when the distribution 
of cardiomyocytes in the different phases of the cell cycle was 
analyzed by fl  ow cytometry after propidium iodide (PI) stain-
ing, the percentage of cells in the G1 and S phases was found to 
progressively decrease along with cardiomyocyte differentiation 
in favor of a G2/M-specifi  c profi  le (  Fig. 2 D  ). This result is in 
agreement with analogous fi  ndings presented in the accompany-
ing manuscript by   Campa et al. (see p. 129 of this issue)  . 
At days 1, 3, and 7 after plating, the levels of expression of in-
dividual genes in the Notch pathway were assessed by transcript-
specifi  c RT-PCR in both purifi  ed cardiomyocyte and stromal 
cell cultures (  Fig. 2 E  ). At day 1, ICMs expressed high levels of 
Notch1, whereas Notch2 was barely detectable; the levels of 
Notch1 appeared to progressively decrease along cardiomyo-
cyte differentiation and became almost undetectable at day 7. 
In a reciprocal fashion, the levels of Jagged1 in cardiomyocytes 
progressively increased with time; Jagged2 and Delta1 were not 
detected at any time in these cells. In supporting stromal cells, 
no expression of Notch1 was detectable at day 1, whereas its 
levels progressively increased at days 3 and 7. In contrast, at all 
  Figure 3.       Numb expression is developmen-
tally regulated in cardiomyocytes.   (A and B) 
RT-PCR (A) and Western blot (B) analyses for 
Numb expression in cultured cardiomyocytes 
(CM). (C) Immunoﬂ   uorescence staining for 
Numb along cardiomyocyte differentiation. 
Green,     -actinin; red, Numb; blue, DNA 
(DAPI). (D) Asymmetrical Numb localization 
in adjacent ICMs. The largest ﬁ  gure in each 
panel shows ﬂ   uorescence in all three chan-
nels; the two smaller ﬁ  gures show the blue/
green (top) and red/blue (bottom) channels. 
Green,     -actinin; red, Numb; blue, DNA. 
Bars, 10   μ  m.     121  NOTCH PATHWAY IN CARDIOMYOCYTES   • Collesi et al. 
sion that CBF1 reporter activation in cultured cardiomyocytes 
was strictly dependent on Notch1 activity. 
  To assess whether the block of Notch activation by 
    -secretase inhibition might impair cardiomyocyte proliferation, 
the levels of BrdU incorporation at days 1, 3, and 7 of culture 
were analyzed. Treatment with DAPT determined a marked de-
crease in the number of BrdU-positive cardiomyocytes at days 
1 and 3, respectively (  Fig. 4 C  ). 
  When the same analysis was performed in cultures of stromal 
cells, DAPT was also found to signifi  cantly decrease the prolif-
erative potential of these cells at day 7 only (  Fig. 4 D  ), which is 
consistent with a role of Notch1 activation in sustaining also the 
proliferation of these cells at later time points. Cardiomyocyte 
Western blot analyses, and in contrast to cardiomyocytes, stromal 
cells were positive for both anti-Notch1 antibodies at days 3 and 7. 
The Notch ligand Jagged1 was not detectable in ICMs at day 1, 
whereas an increasingly stronger signal was detected at later 
times, as the cardiomyocyte acquired a fully differentiated 
and beating phenotype. Stromal cells showed a strong immuno-
reactivity for Jagged1 at all time points. 
  To further characterize the in vitro differentiation of neo-
natal ICMs, we analyzed the pattern of expression of Numb, an 
inhibitor of Notch signaling that interacts with the intracellular 
portion of Notch and prevents its nuclear translocation (  Guo 
et al., 1996 ;  Wakamatsu et al., 1999 ). At day 1, Numb expression 
was almost undetectable in ICMs, although it gradually increased 
at day 3 and 7, as detected by both transcript-specifi  c PCR and 
Western blotting (  Fig. 3, A and B  , respectively). 
  The levels of Numb along cardiomyocyte differentiation 
were further analyzed by immunofl  uorescence staining using 
specifi  c antibodies. The protein was expressed at very low levels 
at day 1, though its levels progressively increased at days 3 and 7 
(  Fig. 3 C  ). Interestingly, asymmetrical intracellular localiza-
tion of Numb was detected in dividing cardiomyocytes at day 1 
(  Fig. 3 D  ), which suggests that Numb-mediated Notch down-
regulation might participate in the loss of replicative potential 
and differentiation of ICMs. 
  Together, these results show that the loss of proliferative 
potential of isolated cardiac myocytes parallels the down-regulation 
of expression of the Notch1 receptor and the progressive ex-
pression of Jagged1. In contrast, Jagged1 is constantly expressed 
in supporting stromal cells, whereas the levels of Notch1 increase 
over time and parallel their increased proliferation rate. 
  Inhibition of Notch signaling blocks 
cardiomyocyte proliferation and 
induces apoptosis 
  To further investigate the role of Notch1 activation in primary 
cardiomyocytes, cells at different days of culture were transfected 
with a luciferase construct under the control of two different 
Notch1-responsive promoters: the natural HES1 promoter (  Jarriault 
et al., 1995  ) and an artifi  cial promoter containing four repeats of 
the CBF1 binding sites (HES1 and CBF1 reporters, respectively; 
  Hsieh et al., 1996  ). Parallel to the Notch1 transcript and protein 
levels, activation of the natural HES1 reporter was high at day 1, 
although it progressively decreased at later times (an approx-
imately fi  vefold decrease in promoter activation between day 1 
and 7;   Fig. 4 A  ). Interestingly, this promoter turned out to be in-
hibited by the     -secretase inhibitor only in differentiated cardio-
myocytes at days 3 and 7, whereas it was totally unaffected by 
  N -( N -[3,5-difl  uorophenacetyl]-L-alanyl)-S-phenylglycine t-butyl 
ester (DAPT) treatment in ICMs (  Fig. 4 A  ). This observation 
prompts us to speculate that, in immature cardiomyocytes, the 
HES1 promoter might be a direct target of CREB activation, as 
demonstrated in other cell types (not further investigated here; 
  Herzig et al., 2003  ). The CBF1 reporter showed an identical re-
sponse at the various time points (  >  40 decrease in promoter acti-
vation between day 1 and day 7;   Fig. 4 B  ); cell treatment with 
DAPT markedly suppressed promoter activation (a more than 
fi  vefold decrease at day 1), which is consistent with the conclu-
  Figure 4.       Inhibition of Notch signaling blocks cardiomyocyte proliferation 
and induces apoptosis.   (A and B) DAPT treatment markedly suppresses 
both HES1- and CBF1-luciferase reporter activation. DMSO-containing 
buffer (Control) or DAPT in DMSO buffer (DAPT) was added to cardiac 
myocytes for 24 h after reporter gene transfection; the transactivation ef-
fect was evaluated at the indicated time points. The histogram shows mean 
values   ±   SEM,   n   = 6. **, P   <   0.001. (C and D) DAPT blocks proliferation 
in cardiomyocytes and stromal cells. Puriﬁ  ed cardiac myocytes and, in a 
mirror experiment, stromal cells were cultured in the presence of DAPT or 
DMSO-containing buffer (Control). After pulse-labeling with BrdU and spe-
ciﬁ  c immunostaining, the total number of BrdU+ cells per well was evalu-
ated. The histograms show mean   ±   SEM of the percentage of BrdU+ nuclei 
from at least three views of     200 cells per view. Results are representa-
tive of at least three independent experiments. **, P   <   0.001. (E) DAPT 
treatment markedly increases cardiomyocyte apoptosis through a speciﬁ  c 
Notch-dependent pathway. A TUNEL assay was performed on cardiomyo-
cytes in the presence of DAPT or DMSO buffer (Control). Transduction with 
AAV8-N1ICD protected cardiac myocytes from apoptosis at days 3 and 7, 
although it was ineffective at day 1, which is consistent with the delayed 
kinetics of AAV transduction. The histograms show mean   ±   SEM of the per-
centage of BrdU+ nuclei from at least three views of     200 cells per view. 
Results are representative of at least three independent experiments. **, 
P   <   0.001. (F) Representative images of TUNEL-positive cardiomyocytes 
(day 1 of culture) upon DAPT or DMSO buffer (Control) treatment. Green, 
    -actinin; red, TUNEL-positive nuclei; blue, DNA (DAPI). Bar, 50   μ  m.     JCB • VOLUME 183 • NUMBER 1 • 2008  122
  Gene transfer in primary cardiac myocytes can be effi  ciently 
achieved using viral vectors based on the adeno-associated virus 
serotype 8 (AAV8), as shown in Fig. S2 (available at http://www
.jcb.org/cgi/content/full/jcb.200806091/DC1). The constitutive 
expression of the activated Notch1 ICD (N1-ICD), driven by 
AAV8, provided significant protection to cardiac myocytes 
from apoptosis (    4 and     1.5% of apoptotic cells at days 3 and 7 
after transduction, respectively, as compared with 9.22 and 3.3% 
treatment with DAPT was found to markedly increase the num-
ber of apoptotic cells at day 1 (from 3.6 to 26%), as assessed by 
the TUNEL assay (  Fig. 4 E   for quantifi  cation and   Fig. 4 F   for 
representative images). Of interest, the induction of apoptosis 
upon     -secretase inhibition was progressively less profound at 
the later time points (9.3 and 3.6% of apoptotic cells at days 3 
and 7, respectively, compared with 3.9 and 3.3% normally de-
tected at the same time points in the absence of any treatment). 
  Figure 5.       sJ1 and Notch-ICD transduction enhance cardiomyocyte proliferation.   (A) Treatment with sJ1 activates HES1 promoter transcription. Neonatal 
cardiomyocytes were assayed for HES1 reporter transactivation upon stimulation with conditioned medium from NIH-3T3 cells secreting sJ1 or rFc-sJ1 
either preclustered on Sepharose beads or immobilized on plates. The respective controls were the supernatant from mock-transfected NIH-3T3 cells (Con-
trol), Sepharose-IgG, and immobilized IgG. The transactivation effect was evaluated at the indicated time points after reporter transfection. The histogram 
represents mean values   ±   SEM,   n   = 6. **, P   <   0.001. (B) Treatment with sJ1 markedly enhances expression of the CBF1-luciferase reporter. Control or 
sJ1-conditioned medium (sJ1) was added to cardiomyocytes for 24 h after reporter transfection; the transactivation effect was evaluated at the indicated 
time points. The histogram represents mean values   ±   SEM,   n   = 6; **, P   <   0.001. (C) sJ1 stimulation increases BrdU incorporation in cardiac myocytes. 
Neonatal cardiomyocytes were cultured in the presence of either sJ1- or control-conditioned medium, or either hIgG or rFc-sJ1 ligand preclustered onto 
Sepharose beads, and pulsed for BrdU incorporation. In a mirror experiment, neonatal cardiomyocytes were seeded onto rFc-sJ1 (or normal h-IgG as a 
control) precoated slides. After BrdU immunostaining, the total number of BrdU+ cells per well was scored. The histograms show mean   ±   SEM of the percent-
age of BrdU+ nuclei from at least three ﬁ  elds of     200 cells per ﬁ  eld. Results are representative of at least three independent experiments. **, P   <   0.001. 
(D) Low (panels a, b, g, h, o, and p)- and high (panels c  –  f and i  –  n)-magniﬁ  cation representative images of BrdU+ cardiomyocytes at different time points, 
after treatment with control- or sJ1-conditioned medium. Green,     -actinin; red, BrdU; blue, DNA (DAPI). Bars: (low magniﬁ  cation) 50   μ  m; (high magniﬁ  ca-
tion) 10   μ  m. The examples shown are representative of more than ﬁ  ve experiments with similar outcomes. (E) sJ1 remarkably stimulates cardiomyocyte 
proliferation. Cardiac myocytes were cultured in the presence of sJ1 (sJ1)- or control-conditioned media. After speciﬁ  c immunostaining, the total number of 
    -actinin  –  positive cells per well was scored. The histogram shows mean   ±   SEM of at least 8 wells per time point from three independent experiments. **, 
P   <   0.001. (F) AAV8-N1ICD strongly stimulates BrdU incorporation in cardiomyocytes. Neonatal cardiomyocytes were infected either with AAV8-LacZ or 
AAV8-N1ICD and pulsed for BrdU incorporation at different time points. After BrdU immunostaining, the total number of BrdU+ cells per well was scored. 
The histograms show mean   ±   SEM of the percentage of BrdU+ nuclei from at least three ﬁ  elds of     200 cells per ﬁ  eld. Results are representative of at least 
three independent experiments. **, P   <   0.001. (G) SJ1 stimulates BrdU incorporation in stromal cells. Stromal cells were cultured in the presence of sJ1 
(sJ1)- or control-conditioned medium and pulsed for BrdU incorporation. After BrdU immunostaining, the total number of BrdU+ cells per well was scored. 
The histograms show mean   ±   SEM of the percentage of BrdU+ nuclei from at least three ﬁ  elds of     200 cells per ﬁ  eld. **, P   <   0.001.     123  NOTCH PATHWAY IN CARDIOMYOCYTES   • Collesi et al. 
apoptotic cells detected at the same time points in the presence of 
DAPT;   Fig. 4 E  ). Of notice, the proapoptotic effect of DAPT was 
not rescued by AAV8-N1ICD transduction at day 1, a result that 
is consistent with the kinetics of transgene expression after AAV8 
transduction, which reaches its maximum at 72 h after infection 
(Fig. S2). This fi  nding is consistent with the biology of AAV 
transduction in a variety of other cell types in vitro and in vivo 
(  Palomeque et al., 2007  ;   Zincarelli et al., 2008  ). 
  Together, these results strongly indicate that Notch1 activa-
tion at the early time points not only triggers cell proliferation but 
is also required to maintain cell viability and prevent apoptosis. 
  Soluble Jagged1 enhances 
cardiomyocyte proliferation 
  The observation that the inhibition of the Notch pathway im-
pairs cardiomyocytes proliferation suggested that, on the con-
trary, its stimulation might lead to their increased proliferation. 
To directly assess this possibility, we cultured freshly isolated 
neonatal cardiomyocytes in the presence of different sources of 
its Jagged1 ligand, including conditioned medium from NIH-3T3 
cells secreting a soluble form of Jagged1 (sJ1;   Wong et al., 2000  ) 
and recombinant fragment crystallizable (Fc)-fused soluble 
Jagged1 (rFc-sJ1) either preclustered on Sepharose beads (  Vas 
et al., 2004  ) or immobilized on plates (  Koyanagi et al., 2007  ). 
Immature cardiomyocytes at day 1, cultured in the presence of 
any of the three sources of sJ1, showed a marked up-regulation 
of the HES1 promoter (  Fig. 5 A  ). This transactivation effect was 
still evident at day 3, although it became almost undetectable in 
differentiated cardiomyocytes at day 7. A conditioned medium 
containing the Delta1 ligand had no apparent effect when used 
under the same conditions (unpublished data). Of interest, the 
conditioned medium containing sJ1 was even more potent than 
the two forms of immobilized rFc-sJ1, which is consistent with 
the possibility that sJ1 might spontaneously cluster on the sur-
face of the target cells by virtue of its interactions with various 
proteins of the extracellular matrix and cell surface, as already 
described for other soluble growth factors (for reviews see 
  Taipale and Keski-Oja, 1997  ;   Cool and Nurcombe, 2006  ;   Guerrini 
et al., 2007  ). In a consistent manner, sJ1 was also able to acti-
vate transcription of the CBF1 promoter in cardiomyocytes at 
days 1 and 3 (but not at day 7) of culture (  Fig. 5 B  ). The sensi-
tivity to sJ1 stimulation correlated with the presence of the ac-
tive Notch1 receptor in cardiac myocytes. Upon sJ1 stimulation, 
day-1 and, to a lesser extent, day-3 cardiomyocyte extracts 
showed markedly increased levels of N1-ICD, whereas DAPT 
treatment completely abolished the signal in sJ1-stimulated car-
diac myocytes at any time point; no signal was detected using 
the Val 1744 antiserum in day-7 cardiac myocytes under any con-
dition (Fig. S1 A). 
  Consistent with the transactivation results, the treatment 
of neonatal cardiomyocytes with either sJ1 or the two different 
types of immobilized rFc-sJ1 proteins determined a marked 
increase in the extent of BrdU incorporation. The number of 
BrdU-positive cells was     34% in the sJ1-treated sample versus 
7% in the absence of treatment at day 1, and 11% versus 4.4% 
at day 3; BrdU incorporation was consistently increased upon 
treatment with immobilized rFc-sJ1 (quantifi  cation and repre-
sentative images are shown in   Fig. 5 (C and D  , respectively). 
At day 7 of culture, when Notch1 was no longer expressed in 
cardiomyocytes, sJ1 addition had no apparent effect on BrdU 
incorporation. Remarkably, the activation of the Notch1 path-
way by sJ1 lead to a signifi  cant increase in the total number of 
cardiomyocytes in culture, which, at day 7 of stimulation, was 
almost fi  vefold compared to the control (  Fig. 5 E  ). The effect of 
Notch1 stimulation on cardiomyocyte proliferation was further 
strengthened by the observation that the forced expression of 
N1-ICD in cardiomyocytes by AAV8-N1ICD transduction 
stimulated BrdU incorporation in day-3 and, remarkably, also in 
day-7 cardiomyocytes (21.1% vs. 2.8% in AAV8-N1ICD vs. 
AAV-LacZ transduced cardiomyocytes;   Fig. 5 F  ). 
  Finally, in contrast to cardiomyocytes, sJ1 did not affect 
BrdU incorporation in stromal cells at day 1, in keeping with 
the absence of the Notch1 receptor in these cells at this time 
point (  Fig. 5 G  ). At days 3 and 7, when Notch1 became ex-
pressed, the number of cells incorporating BrdU started to in-
crease, although at a level remarkably lower than in early 
cardiomyocytes (17.2% vs. 11% BrdU-positive stromal cells at 
day 7 in the presence or absence of sJ1, respectively). 
  Figure 6.       Notch1 activation parallels cardiomyocyte proliferation.   (A) sJ1 
treatment activates cell cycle  –  related signaling. Cardiomyocytes were cul-
tured in the presence of control (    )- or sJ1-conditioned medium (+) before 
immunoblotting for cell cycle  –  speciﬁ  c effectors. (B) Model of Notch1-
dependent regulation of ICM proliferation and differentiation. See Discussion 
for details. Bars, 10   μ  m.     JCB • VOLUME 183 • NUMBER 1 • 2008  124
plating), and extend their lifespan in culture. However, Notch re-
ceptor activation does not revert newly formed cardiomyocytes 
back into precursor cells but keeps the ICM proliferating window 
open for a longer time, stimulating their increase in number. 
  The early embryonic lethality caused by cardiovascular de-
fects of mice lacking genes of the Notch signaling cascade strongly 
supports a key function for Notch in the process of cardiac and 
vascular development (  Loomes et al., 1999  ;   Rones et al., 2000  ; 
  Loomes et al., 2002  ; for reviews see   High and Epstein, 2008  ; 
  Niessen and Karsan, 2008  ). Indeed, Notch signaling has been 
found to exert a suppressive role during myocardial specifi  cation in 
several different species (  Park et al., 1998  ;   Rones et al., 2000  ;   Han 
and Bodmer, 2003  ;   Chau et al., 2006  ). Consistent with these fi  nd-
ings, several in vitro studies have also implied a suppressive role of 
Notch on mesodermal commitment and cardiac differentiation. 
RBP-J – defi  cient embryonic stem cells show enhanced mesoder-
mal and cardiogenic differentiation, which is likely attributable to 
the lack of Notch signaling (  Schroeder et al., 2003  ;   Nemir et al., 
2006  ;   Schroeder et al., 2006  ). In addition, constitutive activation of 
Notch in mesodermal progenitors blocks cardiomyocyte produc-
tion in vitro (  Schroeder et al., 2006  ), and forced Notch expression 
in mesodermal cardiac progenitor cells expressing Mesp1 during 
development prevents cardiogenesis and results in cardiac abnor-
malities in transgenic mice (  Watanabe et al., 2006  ). 
  The contradiction between the fi  ndings postulating a sup-
pressive role of Notch during early cardiac development and 
our results, which clearly show that Notch activation is essential 
to promote ICM proliferation, is only apparent. In fact, Notch 
signaling is known to be exquisitely sensitive to dosage, devel-
opmental timing, and cellular context (  Artavanis-Tsakonas et al., 
1999  ). It is therefore not surprising that, after mesodermal spec-
ifi  cation and cardiac commitment, the reactivation of Notch sig-
naling is required to sustain the proliferation of the pool of 
ICMs still able to undergo mitosis. 
  Our results demonstrate the existence, both in vitro and in 
vivo in neonatal animals, of a pool of N1-ICD  –  positive cells that 
express early cardiac markers (GATA4 and Nkx2.5) and incorpo-
rate BrdU. Loss of the proliferative potential of these cells parallels 
the progressive disappearance of Notch1, which is consistent with 
the conclusion that Notch1 might primarily act by preventing ter-
minal differentiation in this expanding proliferating compartment. 
On the basis of the knowledge currently available on Notch func-
tion and our results, we would like to propose the following model 
(  Fig. 6 B  ). Although Notch1 is essential to sustain ICM prolifera-
tion, its levels progressively decrease in vitro parallel to cardio-
myocyte differentiation. This determines a progressive withdrawal 
of differentiated cardiomyocytes from the cell cycle. By a positive 
feedback regulation, the Jagged1 ligand starts to be expressed on 
the surface of these cells. At this point, by a lateral induction mech-
anism, cardiac myocytes themselves behave as signal-sending cells 
to their stromal counterparts, the proliferation of which is also sus-
tained at later stages of culture by activation of de novo expressed 
Notch1 itself. This model is also consistent with the observation 
that the levels of expression of the Notch antagonist Numb increase 
as long as the ICM proliferation diminishes, thus inversely cor-
relating with the levels of Notch1. An asymmetrical localization 
of Numb has been described during embryogenesis, where it is 
  Notch1 activation parallels cell cycle 
protein expression in 
immature cardiomyocytes 
  The levels of several proteins involved in cell cycle regulation were 
analyzed by immunoblotting in cardiomyocytes at different time 
points in culture and upon sJ1 stimulation. The arrest in proliferation 
and decrease in BrdU incorporation over time were found to corre-
late with the progressive increase of the cyclin-dependent kinase 
inhibitors (CKIs) p21Cip1 and p27Kip1, and of the Cdt1 inhibitor 
geminin (  Fig. 6 A  ;   Wohlschlegel et al., 2000  ). Consistent with 
the increase of these factors, the levels of cyclin D1, cyclin A, and 
cyclin E were signifi  cantly lower in cardiomyocytes at days 7 and 
14 of culture. These observations reinforce similar fi  ndings of 
 Campa  et  al. (2008)   on the specifi  c role of cyclin D1 regulation in 
the cardiomyocyte cell cycle. Remarkably, sJ1 stimulation reversed 
cell cycle exit at days 1 and 3, whereas it had no effect at later stages. 
Cardiomyocyte proliferation correlated with the presence of high 
levels of phosphorylated p38 MAPK; conversely, differentiated 
cells expressed Y705-phosphorylated p-STAT3, a known marker of 
terminal differentiation in other tissues (  Androutsellis-Theotokis 
et al., 2006  ). The sensitivity to sJ1 stimulation was strictly depen-
dent on the presence of the Notch1 receptor on cardiomyocytes. 
At days 1 and 3, both the Notch1 precursor p300 and the cleaved 
p120 and p110 forms were present, and sJ1 stimulation further in-
creased their levels while inhibiting its own expression (evident at 
day 3 in   Fig. 6 A  ). At days 7 and 14, p300 was undetectable, and its 
cleaved forms progressively disappeared. In contrast, expression of 
Jagged1 became detectable and was negatively regulated by sJ1 
stimulation in a negative feedback loop. Collectively, these results 
support the conclusion that Notch activation powerfully stimulates 
immature cardiac myocyte proliferation and expansion during the 
early times of culture, whereas it progressively becomes ineffective 
along the differentiation process and is incapable on its own to pro-
mote reentry of differentiated cardiomyocytes into the cell cycle. 
  Discussion 
  In this study, we provide evidence that activation of the Notch1 
pathway maintains proliferation and permits expansion of 
ex vivo cultured ICMs. We found that Notch1 is highly expressed 
by immature, still dividing, cardiac myocytes, whereas Jagged1 
is mainly expressed on supporting stromal cells. The loss of 
proliferative potential by isolated myocytes parallels the down-
regulation of the Notch1 receptor and the progressive expres-
sion of Jagged1. On the contrary, we show that the sustained, 
constitutive activation of Notch1 signaling directly correlates 
with an increase in ICM proliferation. 
  Our results indicate that the multidirectional Notch receptor/
ligand signaling paradigm also extends to cardiac cells. According 
to this paradigm, it can be envisaged that the stromal microenviron-
ment, expressing Jagged1, triggers an inductive signal to ICMs to 
expand their number, keeping them in a highly proliferative state. 
This is supported by our observation that activation of Notch sig-
naling by both exogenous soluble ligand stimulation and intracel-
lular AAV-mediated constitutive expression of N1-ICD enhance 
ICM proliferation, delay newly formed cardiomyocytes from rapid 
differentiation into mature beating cells (normally within 24 h from 125  NOTCH PATHWAY IN CARDIOMYOCYTES   • Collesi et al. 
plasmid was provided by R. Kopan (Molecular Biology and Pharmacology, 
Washington University, St. Louis, MO); the Delta1Fc construct (  Wang 
et al., 1998  ) was provided by G. Weinmaster (David Geffen School of 
Medicine at University of California, Los Angeles, Los Angeles, CA); wild-
type (4xwtCBF1Luc) and mutant (4xmtCBF1luc) reporters were provided by 
S.D. Hayward (John Hopkins University School of Medicine, Baltimore, 
MD); and the pHes1-Luc reporter construct was provided by R. Kageyama 
(Institute for Virus Research, Kyoto University, Kyoto, Japan). 
  Anti-Notch-1 (C-20), anti-Jagged1 (H-114), anti-Delta (F15), anti  –  -
cyclin-A (C19), anti  –  cyclin-D1 (C20), anti  –  cyclin-E (C19), anti-p27Kip1 
(C-19), and anti  –  GATA-4 antibodies were obtained from Santa Cruz Bio-
technology, Inc.; anti  –  cleaved Notch-1 (Val1744), anti  –  phospho-p38 MAPK, 
and anti  –  phospho-STAT3 (Tyr705) were obtained from Cell Signaling Tech-
nology; antisarcomeric     -actinin (EA-53) and anti-p21Cip1 antibodies were 
obtained from AbCam; anti-Numb antibodies were obtained from Millipore; 
and FITC-coupled anti-BrdU antibodies were obtained from BD Biosciences. 
Anti-geminin antibodies were a gift from R. Laskey (Hutchinson/Medical 
Research Council Research Center, Cambridge, UK). 
  BrdU was obtained from Boehringer-Mannheim/Roche. Hoechst 
33258, PI, RNase A, and all other chemicals were purchased from 
Sigma-Aldrich. 
  Production, puriﬁ  cation, and characterization of rAAV vectors 
  rAAV vectors were prepared by the AAV Vector Unit at the International 
Centre for Genetic Engineering and Biotechnology Trieste (http://www
.icgeb.org/RESEARCH/TS/COREFACILITIES/AVU.htm), as described pre-
viously (  Arsic et al., 2004  ). In brief, infectious AAV8 vector particles were 
generated in HEK293 cells by cotransfecting each vector plasmid (pAAV-
N1ICD and pAAV-LacZ) together with the packaging plasmid (pAAV8-2; 
  Gao et al., 2002  ) and helper plasmid (pHELPER; Stratagene), expressing 
AAV and adenovirus helper functions, respectively. Viral stocks were ob-
tained by CsCl  2   gradient centrifugation; rAAV titers, determined by mea-
suring the copy number of viral genomes in pooled, dialyzed gradient 
fractions, as described previously (  Zentilin et al., 2001  ), were in the range 
of     10 
12   to     10 
13   genome copies per milliliter. 
  Animals 
  Animal care and treatment were conducted in conformity with institutional 
guidelines in compliance with national and international laws and policies 
(European Economic Community Council Directive 86/609, OJL 358, Decem-
ber 12, 1987). Wistar rats were purchased from Charles River Laboratories 
Italia Srl and maintained under controlled environmental conditions. When in-
dicated, animals were treated for 2 d with 20 mg/kg of BrdU before killing. 
  Culture of neonatal rat cardiomyocytes 
  Neonatal rat ventricular myocytes were plated at low density in DME/4.5 g 
glucose containing 5% bovine calf serum and 2 mg/ml vitamin B12 and cul-
tured as described previously (  Deng et al., 2000  ). In brief, ventricles from 2  –  3 
litters of neonatal Wistar rats were separated from the atria using scissors and 
then dissociated in CBFHH (calcium and bicarbonate-free Hanks with Hepes) 
buffer containing 2 mg/ml of trypsin and 20   μ  g/ml of DNase II. Cells were 
preplated for 2 h into 100-mm dishes in DME containing 5% deﬁ  ned bovine 
calf serum (HyClone); stromal cells were then separated from unattached myo-
cytes that were plated at a density of 500 cells/mm 
2   into 60-mm dishes (for 
protein signaling, cytochemistry, RNA, and protein analysis; Falcon), multi-well 
plates (for biochemical assays; Costar) or multiwell slides coated with 0.2% 
gelatin (for immunoﬂ  uorescence staining). For RT-PCR and Western blot analy-
ses, three subsequent 1-h-long preplating steps were performed in order to 
strongly enrich the cell preparations in cardiomyocytes (    90% purity). For the 
experiments involving cardiomyocyte transduction using AAV vectors, neona-
tal rat cardiomyocytes, immediately after plating onto 4-well slides coated with 
0.2% gelatin at a density of 5   ×   10 
4   cells per well, were infected with 2   ×   10 
10   
genome copies per well. After 12 h, the culture medium was changed and 
cells were subjected to the different treatments and subsequent analyses. 
  RT-PCR analysis 
  Total mRNA was puriﬁ  ed from cultured cardiomyocytes at 1, 3, or 7 d after 
plating. mRNA was reverse-transcribed using Superscript II (Invitrogen) 
with random hexamers (10   μ  M) as a primer in a 35-  μ  l reaction containing 
1  ×   Superscript II RT buffer (Invitrogen), 10   μ  M dATP, dTTP, dCTP, and dGTP, 
and 20 U RNasin (Invitrogen). After 2 h at 42  °  C, the reaction was termi-
nated by adding 365   μ  l of H  2  O and boiling for 2 min. For PCR ampliﬁ  ca-
tion, speciﬁ  c primer pairs (0.5   μ  M each) were incubated with 50 ng cDNA 
and 1 U Herculase enhanced DNA polymerase (Stratagene) in a 20-  μ  l re-
action mixture that included 1  ×   buffer and 100   μ  M dATP, dCTP, dGTP, and 
dTTP. Typical cycle parameters were 1 min at 92  °  C, 1 min at 59  °  C, and 3 min 
  involved in cell fate determination in different tissues (  Rhyu et al., 
1994  ;   Carmena et al., 1998  ;   Park et al., 1998  ;   Artavanis-Tsakonas 
et al., 1999  ;   Wakamatsu et al., 1999  ) and in satellite cell activation 
during skeletal muscle regeneration (  Conboy and Rando, 2002  ). 
Moreover, high levels of Notch signaling lead to a reduction of 
Numb protein, revealing a reciprocal negative regulation between 
Notch and Numb (  Chapman et al., 2006  ). Our results indicate that 
this regulation also occurs in mammalian cardiomyogenesis. 
Whether Numb expression might also play a role in vivo still re-
mains to be determined. In this respect, however, it is intriguing to 
notice that Numb-positive progenitor cells have been found in the 
adult mouse heart, lying in defi  ned interstitial structures reminis-
cent of stem cell niches (  Urbanek et al., 2006  ). 
  ICM cells showed shortening of the G1 phase, showed 
low or undetectable levels of the p27Kip1 and p21Cip1 CKIs 
and of the Cdt1 inhibitor geminin, and expressed cyclins D1, A, 
and E, an overall profi  le that is characteristic of cells with a high 
replicative turnover. In addition, cell treatment with sJ1 further 
enhanced these features. In contrast, fully differentiated cardio-
myocytes expressed abundant levels of CKIs, whereas the G1/S 
cyclins became almost undetectable. These features are per-
fectly in agreement with the observations presented in the ac-
companying paper by   Campa et al. (2008)  , which shows that the 
forced activation of Notch2 by ICD gene transfer promotes re-
entry of cardiomyocytes into the cell cycle but does not bypass 
a checkpoint that blocks these cells in the G2/M phase. 
  Our experiments raise the possibility that the Notch pathway 
might also mediate the expansion of the pool of ICMs through pro-
tection from apoptotic cell death. Indeed, we observed that 
    -secretase  –  mediated block of Notch signaling in ex vivo cul-
tured ICMs leads to massive cell apoptosis and that this effect is 
prevented by N1-ICD transduction. In this respect, it is worth noting 
that the role of Notch signaling in the regulation of apoptosis 
in other mammalian systems is not univocal (  Mason et al., 2000  ; 
  Lutolf et al., 2002  ;   Noseda et al., 2004  ) and might thus be depen-
dent on the differentiation and proliferation state of the cells. 
  Collectively, in this work, we provide the fi  rst evidence 
that activation of the Notch pathway mediates the expansion of 
a pool of immature still-dividing cardiac myocytes by promot-
ing their proliferation and protecting them from apoptosis. Our 
results also show that the in vitro treatment of neonatal cardio-
myocyte cultures with an sJ1 agonist, although highly success-
ful in expanding ICM proliferation at earlier stages, becomes 
totally ineffectual when Notch1 is no longer expressed. These 
observations are contrary to the possibility that treatment with 
sJ1 might reverse differentiation but prompt its use for the in 
vitro expansion of the pool of immature, still-proliferating car-
diomyocytes. Thus, sJ1 might turn out to be a powerful growth 
factor able to expand the dividing cardiac precursor cell popula-
tion when starting with various sources of cardiac stem cells. 
  Materials and methods 
  Constructs, cell lines and antibodies 
  The insertless pMEXneo and sJ1 constructs, together with stable NIH-3T3 
transfectants, were provided by I. Prudovsky (Center for Molecular Medi-
cine, Maine Medical Center Research Institute, Scarborough, ME) and 
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polyclonal anti-Jagged1 (H-114), 1:100 (Santa Cruz Biotechnology, Inc.); 
mouse anti  –      -sarcomeric actinin (EA-53), 1:100 (AbCam); rat monoclonal 
(BU1/75) anti-BrdU, 1:100 (AbCam); FastImmune anti-BrdU monoclonal anti-
bodies with Dnase (Becton Dickinson); and mouse monoclonal anti-GATA4 
(G-4), 1:100 (Santa Cruz Biotechnology, Inc.). The secondary antibodies used 
were as follows: goat anti  –  mouse conjugated to Alexa Fluor 488; goat anti  –
  rabbit conjugated to Alexa Fluor 594; and donkey anti  –  rat conjugated to Al-
exa Fluor 488, all at 1:1,000 (Invitrogen). Cells were ﬁ  xed in PBS containing 
3% PFA and 2% sucrose for 10 min; aldehydes were quenched with 0.1 M 
glycine in PBS for 15 min at room temperature. Cells were permeabilized with 
0.1% Triton X-100 for 5 min, blocked in 2% BSA and 0.05% sodium azide in 
PBS (blocking buffer) for 1 h, and incubated with primary antibodies from 2 h 
to overnight. Alexa Fluor 488  –   or Alexa Fluor 594  –  conjugated secondary 
antibodies (Invitrogen) were incubated for 30 min to 1 h at room temperature. 
All washes were in PBS 0.2% Tween 20. Cell nuclei were stained with DAPI, 
and samples were mounted in Vectashield (Vector Laboratories) with ProLong 
Gold (Invitrogen). For histological analysis, frozen sections (5-  μ  m-thick) were 
ﬁ  xed in cold acetone (    20  °  C) and blocked for 30 min with 5% goat or horse 
serum in PBS, depending on the secondary antibody. Primary antibodies were 
used diluted 1:100 in blocking buffer (2% BSA and 0.05% sodium azide in 
PBS). Secondary antibodies used were Alexa Fluor 488  –   or Alexa Fluor 
594  –  conjugated antibodies (Invitrogen). Nuclei were counterstained with 
DAPI. Images were acquired at room temperature with a DMLB upright ﬂ  uores-
cence microscope (Leica) equipped with a charge-coupled device camera 
(CoolSNAP CF; Roper Scientiﬁ  c) using MetaView 4.6 quantitative analysis 
software (MDS Analytical Technologies). For image acquisition, the following 
objectives were used: HCX PL Fluotar 100  ×  /1.30 NA, HCX PL apocromatic 
63  ×  /1.32-0.6 NA, HCX PL Fluotar 40  ×  /0.75 NA, HCX PL N-Plan 20  ×  /0.40 
NA, and HCX PL N-Plan 10  ×  /0.25 NA (all from Leica). Within each experi-
ment, instrument settings were kept constant. For all image quantiﬁ  cation, data 
collected from three independent experiments were used to calculate the 
mean, SEM, and p-value using the Student  ’  s   t   test for unpaired samples. 
  To stain for AAV8-LacZ expression, transduced neonatal rat cardio-
myocytes were ﬁ  xed in PBS containing 2% formaldehyde and 0.2% glutar-
aldehyde at 4  °  C for 5 min after 24, 48, and 72 h of culture. After washing 
with PBS three times, sections were stained with 1 mg/ml X-gal in staining 
solution (40 mM sodium phosphate [dibasic], 40 mM citric acid, 150 mM 
NaCl, 2 mM MgCl  2  , 5 mM potassium ferricyanide, and 5 mM potassium 
ferricyanide) at 37  °  C overnight. Cyanide salts and Xgal (5-bromo-4-chloro-
3-indolyl-    -  D  -galactoside; Thermo Fisher Scientiﬁ  c) were added from freshly 
made stocks in PBS and dimethylformamide, respectively. Cells were then 
washed three times with PBS for 5 min each at room temperature before 
microscopic examination and photography. 
  Treatment with sJ1 
  Conditioned media were prepared from subconﬂ  uent pCDNA3.1-SJ1 and 
pMexNeo NIH-3T3 stable transfectants grown for 3 d in 15-cm dishes in the 
presence of 2% FCS DME. Media were centrifuged at low speed to remove 
cellular debris and concentrated 20-fold with a Centriplus-30 ﬁ  lter (Amicon; 
Millipore) at 4  °  C. For the different assays, rat cardiomyocytes were fed in 
serum-free medium supplemented with 10  ×   diluted sJ1 or pMexNeo concen-
trated supernatants, then subjected to analysis at the indicated time points. 
  Treatment with     -secretase inhibitors 
  Neonatal rat cardiomyocytes (2.0   ×   10 
6  ) were plated either on 0.2% gela-
tin-coated microscope slices (for immunoﬂ  uorescence analysis) or on multi-
well plates (for biochemical assays; Costar). To check     -secretase inhibitors 
effect on BrdU incorporation, 10  –  35   μ  M DAPT was added to cell cultures 
and an equal amount of DMSO as a control. After 22 h, cardiomyocytes 
were pulse-labeled with Brdu, and speciﬁ  c staining was performed as de-
scribed in   “  BrdU pulse labeling and detection.  ”   To check DAPT-induced 
apoptosis, 10  –  35   μ  M DAPT and an equal amount of DMSO as a control 
were added to neonatal rat cardiomyocytes plated onto 0.2% gelatin-coated 
glass chamber slides. After 22 h of culture, cardiomyocytes were ﬁ  xed and 
a TUNEL assay was performed as described in   “  TUNEL staining.  ”   To check 
the     -secretase inhibitor  ’  s effect on cleaved Notch-1 intracellular detection, 
10  –  35   μ  M DAPT was added to cell cultures for 22 h; an equal amount of 
DMSO was added as a control. For luciferase assays, 10  –  35   μ  M DAPT was 
added to cell cultures 6 h after the reporter  ’  s transfection and luciferase activ-
ity was checked 24 h later, as described in   “  Luciferase assays.  ”   
  PI staining 
  For PI staining, cells were washed in 1  ×   PBS at room temperature, ﬁ  xed in 
1 ml of cold 70% ethanol, and centrifuged (1,500   g   for 10 min). Cell pel-
lets were resuspended in 0.5 ml of 1  ×   PBS containing 0.2 mg/ml RNase-A 
at 72  °  C for 20 cycles, followed by a cycle at 72  °  C for 7 min. The whole 
reaction was then fractionated on 1.2% agarose gel and the PCR product 
was visualized by ethidium bromide staining. 
  The primers for RT-PCR analysis were as follows: Notch1 forward 
primer, 5    -GCAGCCACAGAACTTACAAATCCAG-3    , and reverse primer, 
5    -TAA  ATGCCTCTGGAATGTGGGTGAT-3     (445-bp ampliﬁ  ed  fragment); 
Notch2 forward primer, 5    -GCTGTCCTCTTCATGCTGCA-3    , and reverse 
primer, 5    -AGCAGAAGTCAAGACAGTC-3     (505 bp); Notch3 forward 
primer, 5    -TTCCAGATTCTCATCAGGAA-3    , and reverse primer, 5    -TCCTG-
GTGG  GCAGAGCAATG-3     (480 bp); Notch4 forward primer, 5    -CCTCA-
AGC  AGGGACCGGGTC-3    , and reverse primer, 5    -AGGC  AGAA  GTG-
GA  TGA  GGAC-3     (280-bp ampliﬁ  ed fragment); Jagged1 forward primer, 
5    -CCA  CAAAGGGCACGGCGAGTG-3    , and reverse primer, 5    -TGCAT  G-
G  GGTT  TTTGATTTGG-3     (668 bp); Jagged2 forward primer, 5    -ACATGC-
T  AT    GA  CAGCGGCGA-3    , and reverse primer, 5    -CCAGG  AACTCCCA  T  G-
TGGGA-3     (480 bp); Delta1 forward primer, 5    -CGACCTCGCAA  CA  G  A-
AAAC-3    , and reverse primer, 5    -ATGGAGACAGCCTGGGTATC-3     (397 
bp); HES1 forward primer, 5    -GGCAGGCGCACCCCGCCTTG-3    , and re-
verse primer, 5    -GCAGCCAGGCTGGAGAGGCT-3     (170 bp); Hes2 forward 
primer, 5    -CTTCTGTTTTCGCTCTGCCTT-3    , and reverse primer, 5    -TC    GA-
G  GT  AG  CTATCCAAAGAC-3     (352 bp); Hes3 forward primer, 5    -TCAG  C  A-
TCTTTA  TCAGGCCTC-3    , and reverse primer, 5    -CTAGCCAAAG  TCCTT  GC-
AA  TG-3     (302 bp); HES5 forward primer, 5    -ACCGCATCAACA  GCA-
GCATT-3    , and reverse primer, 5    -AGGCTTTGCTGTGCTTCAGGT-3     (135 
bp); HEY1 forward primer, 5    -ACCCAATGGACTCCACACATC-3    , and re-
verse primer, 5    -TGTTCCACTGCTTGTCTGCTG-3     (352 bp); HEY2 forward 
primer 5    -GAG  ATCTTGCAGATGACTGTG-3    , and reverse primer, 5    -TGTC-
GAAGGACT  CAGTAGATG-3     (178 bp); Numb forward primer, 5    -AA  A  C-
C  AGTGACA  TTAGTGGC-3    , and reverse primer, 5    -TGAGGCCTGCG  GCT-
GCTGGG-3     (326 bp); and GAPDH forward primer, 5    -ATTGTCAG  C  A-
ATG  CATCC  TGCA-3    , and reverse primer, 5    -AGACAACC  TGG  TCC  T  C-
AGTGTA-3     (320 bp). In all experiments, RT-PCR was performed on total 
embryo RNA as a positive control (+). 
  Western blotting 
  For protein analysis, samples were lysed in RIPA buffer (50 mM Tris-HCl, 
150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 0.5% NaDoc, 1% Triton X-100, 
and 0.1% SDS) containing 90   μ  g/ml PMSF, 1 mM NaVO  4  , 20   μ  g/ml 
aprotinin, and 20   μ  g/ml leupeptin (Sigma-Aldrich). Protein concentration 
was determined by the Bradford method (Bio-Rad Laboratories); equal 
amounts of protein were resolved on SDS-PAGE minigels and transferred to 
nitrocellulose membranes (GE Healthcare). Immunoblots were blocked in 
5% nonfat dry milk in TBST (50 mM Tris-HCl, pH 7.4, 200 mM NaCl, and 
0.1% Tween 20). Membranes were incubated with primary antibodies 
overnight and washed in Tris-buffered saline, 0.1% Tween 20. Secondary 
antibodies were diluted in blocking buffer and incubated with the mem-
branes for 45 min at room temperature. Proteins were detected by en-
hanced chemiluminescence (GE Healthcare). 
  Luciferase assays 
  To detect Notch1 activity under the different experimental conditions, neona-
tal cardiomyocytes were seeded onto 0.2% gelatin-coated 24-well culture 
plates (5   ×   10 
4   cells per well) and cotransfected at the stated time points with 
0.2   μ  g of reporter plasmid and 0.01   μ  g pRL-Renilla (which was used as 
control) by using FuGENE6 transfection reagent (Roche). The pHes1-Luc re-
porter construct, wild-type (4xwtCBF1Luc), and mutant (4xmtCBF1luc) CBF1 
reporters (  Hsieh et al., 1996  ) were cotransfected with the control plasmid 
pRL-CMV (Promega). In some cases, a plasmid expressing Notch1-ICD was 
included as a positive control. After incubation for 6 h, the medium was re-
moved and the cells were fed in serum-free medium with either sJ1 or pMex-
Neo concentrated supernatants and either hIgG or recombinant Fc-sJ1 (R  &  D 
Systems) preclustered onto Sepharose beads (  Vas et al., 2004  ). In a parallel 
experiment, neonatal cardiomyocytes were seeded onto 24-well culture 
plates (5   ×   10 
4   cells per well) precoated with recombinant Fc-sJ1 or normal 
h-IgG as a control (5   μ  g/ml in 0.05 M carbonate-bicarbonate buffer, pH 
9.6). 24 h after treatment, the cell monolayers were washed with PBS, har-
vested by scraping, and resuspended in PLB buffer (Promega). Fireﬂ  y and 
Renilla luciferase activities were assayed with the Dual-luciferase assay kit 
(Promega). Fireﬂ  y luciferase activity was corrected for the transfection efﬁ  -
ciency by using the control Renilla luciferase activity in each sample. 
  Immunocytochemical and immunohistochemical staining 
  The primary antibodies used were as follows: rabbit polyclonal anti-cleaved 
N1 (Val1744), 1:100 (Cell Signaling Technology); both rabbit and goat poly-
clonal anti-Notch1 (C-20), 1:100 (Santa Cruz Biotechnology, Inc.); rabbit 127  NOTCH PATHWAY IN CARDIOMYOCYTES   • Collesi et al. 
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(Roche) and incubated at 37  °  C for 30 min, after which 0.5 ml of 80 mg/ml 
PI (Sigma-Aldrich) was added. Cells were incubated with PI for at least 
10 min at 4  °  C before analysis. PI incorporation was evaluated by ﬂ  ow 
cytometry using a FACSCalibur ﬂ  ow cytometer (Becton Dickinson) and BD 
CellQuest Pro software (Becton Dickinson). 
  BrdU pulse labeling and detection 
  After pulse-labeling of cardiomyocyte with BrdU (10   μ  M for 40 min), BrdU 
staining was performed according to the manufacturer  ’  s instructions (BD 
Biosciences). In brief, cultures were ﬁ  xed in 3% PFA and 2% sucrose in 
PBS, pH 7.6; washed three times for 10 min with PBS 1% Triton X-100; and 
incubated with 1 M HCl for 10 min on ice, 2 M HCl for 10 min at room 
temperature, and with 2 M HCl for 20 min at 37  °  C. After DNA denatur-
ation, cells were incubated with 0.1 M sodium-borate buffer, pH 8.4, for 
12 min at room temperature, then washed three times with PBS 1% Triton 
X-100, blocked with 2% BSA in PBS 1 h at room temperature, and incu-
bated with anti-BrdU antibodies O/N at 4  °  C. All subsequent steps were as 
described in   “  Immunocytochemical and immunohistochemical staining.  ”   
Each slide was then analyzed by counting, in a blind fashion, the number 
of BrdU-positive and BrdU-negative cells over 10 high-magniﬁ  cation ﬁ  elds 
for each condition. BrdU detection on some hystological sections was per-
formed using the FastImmune anti-BrdU monoclonal antibodies with Dnase I, 
according to the manufacturer  ’  s instructions (Becton Dickinson). 
  TUNEL staining 
  Freshly isolated cardiomyocytes were cultured on glass chamber slides 
coated with 0.2% gelatin. At stated time points, 10  –  35   μ  M DAPT was added 
to cell cultures; 24 h later, slides were ﬁ  xed as described in   “  Immunocyto-
chemical and immunohistochemical staining  ”   and then stained for DNA 
fragmentation characteristic of apoptosis by the TUNEL reaction, as de-
scribed previously (  Iredale et al., 1998  ), with the modiﬁ  cations described to 
reduce false positivity (  Stahelin et al., 1998  ). Each slide was then analyzed 
by counting, in a blind fashion, the number of TUNEL-positive and TUNEL-
negative cells over 10 high-magniﬁ  cation ﬁ  elds for each condition. 
  Online supplemental material 
  Fig. S1 shows the detection of activated Notch1 upon either     -secretase or 
sJ1 treatments during cardiomyocyte differentiation. Fig. S2 shows the time 
course of AAV transduction of in vitro cultured cardiomyocytes. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200806091/DC1. 
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